P241 Gastrointestinal ultrasound instead of magnetic resonance enterography: Large potential cost savings with limited clinical downsides von Luber, R, Petri, B, Griffin, N, Irving, P

Volltext

P702 Long term outcomes following de-escalation of dose-intensified ustekinumab in patients with Crohn’s disease von Demase, K, Smith, R L, Luber, R, Taylor, K M, Ward, M G, Sparrow, M P, Little, R D

Volltext

P485 Switching infliximab biosimilar: No adverse impact on inflammatory bowel disease control or drug levels with the first or second switch von Luber, R, O’Neill, R, Singh, S, Arkir, Z, Irving, P

Volltext

P197 Anogenital Crohn’s disease and granulomatosis: A systematic review of epidemiology, clinical manifestations, and treatment von Honap, S, Meade, S, Spencer, A, Pavlidis, P, Luber, R, Calonje, E, Rashid, E, Bunker, C, Lewis, F, Irving, P

Volltext

4CPS-108 A review of infliximab biosimilar to biosimilar switch: Remsima to Flixabi von O’neill, R, Singh, S, Luber, R

Volltext

P128 Depression, anxiety and stress among Inflammatory Bowel Disease patients during COVID-19: A UK cohort study von Luber, R, Duff, A, Pavlidis, P, Honap, S, Meade, S, Ray, S, Anderson, S, Mawdsley, J, Samaan, M, Irving, P

Volltext

P333 Biologic longevity: Withdrawal of drugs due to remission is rare in clinical practice von Sharma, E, Cunningham, G, Dawson, P, D’Errico, F, Honap, S, Lim, S, Luber, R, Meade, S, Pavlidis, P, Reynolds, R, Irving, P

Volltext

P618 Pre-operative oral enteral nutritional optimisation for Crohn’s disease: A retrospective UK tertiary IBD centre cohort study von Meade, S, Patel, K V, Luber, R P, O’Hanlon, D, Caracostea, A, Pavlidis, P, Honap, S, Anandarajah, C, Griffin, N, Zeki, S, Ray, S, Mawdsley, J, Samaan, M A, Anderson, S H, Darakhshan, A, Adams, K, Williams, A, Sanderson, J D, Lomer, M, Irving, P M

Volltext

P386 A target 6-thioguanine nucleotide ≥125 is associated with a higher rate and longer durability of response in infliximab–thiopurine combination therapy: a retrospective study i... von Luber, R., Kariyawasam, V., Dawson, L., Munari, S., Gibson, P., Sparrow, M., Ward, M.

Volltext

P551 6-Thioguanine nucleotide levels are associated with mucosal healing in patients with Crohn’s disease: A multi-centre, international study von Mao, R, Guo, J, Luber, R, Chen, B -l, He, Y, Zeng, Z -r, Ben-Horin, S, Sparrow, M, Xavier, R, Chen, M -h

Volltext

P428 Pharmacist-led proactive therapeutic drug monitoring with infliximab (PROXIMO): Utility of and cost-saving associated with the use of a rapid assay for assessing drug level von Rentsch, C, Sparrow, M, Ward, M, Taylor, K, Friedman, A, Luber, R, Su, H, Hopkins, R, Head-on, B, Dooley, M, Gibson, P

Volltext

Imaging transport for the determination of minority carrier diffusion length von Luber, D. R., Bradley, F. M., Haegel, N. M., Talmadge, M. C., Coleman, M. P., Boone, T. D.

Volltext

An Examination of the Efficacy of Social Skills Training for Chronic Schizophrenic Patients von Bellack, Alan S., Turner, Samuel M., Hersen, Michel, Luber, Raymond F.

Volltext

Direct imaging of electron-beam interaction region von Luber, D. R., Haegel, N. M.

Volltext

POETRY THERAPY HELPS PATIENTS EXPRESS FEELINGS von Luber, Raymond F

Volltext

Lanthanide shift reagents. X-ray structure of the eight-coordinate bis(4-picoline) adduct of 2,2,6,6-tetramethylheptane-3,5-dionatoholmium, Ho(dpm)3(4-pic)2 von Horrocks, William DeW, Sipe, James P, Luber, Joseph R

Volltext

Behavioral treatment in partial hospitalization von Luber, Raymond F.

Volltext

Methods and Systems for Determining Autism Spectrum Disorder Risk von Luber, Jeffrey R, Damian, Doris, Geigenmuller, Ute, Pacula, Maciej, DePristo, Mark A

Volltext bestellen

Methods and Systems for Determining Autism Spectrum Disorder Risk von Luber, Jeffrey R, Damian, Doris, Geigenmuller, Ute, Pacula, Maciej, DePristo, Mark A

Volltext bestellen

Methods and systems for determining autism spectrum disorder risk von Luber, Jeffrey R, Damian, Doris, Geigenmuller, Ute, Pacula, Maciej, DePristo, Mark A

Volltext bestellen